Agenus Inc.
AGEN •
Buy Open
Signal type
Buy
Status
Open
Open Price
$3.55
Stop Loss
$1.93
Performance
32.96%
Days Open
36
Signal Setup
Signal Type Buy
Status Open
Open Date Mar 10, 2026
Open Price $3.55
Stop Loss $1.93
Timespan Day
Company Profile
Name Agenus Inc.
Ticker AGEN
Market Cap $125.30M
Sector BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Latest Close $4.72
List Date Feb 4, 2000
Description
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
Website Open Company Website